Never Run Out Of Buyers To Sell To.

About DEEPSONBIO DEEPSONBIO Co, Ltd. is an innovative biomedical technology company dedicated to developing cutting-edge therapeutic ultrasound devices. Established in 2018, the company focuses on providing non-invasive, non-pharmacological solutions for neurodegenerative conditions like Alzheimer’s disease and Mild Cognitive Impairment (MCI). Its flagship technology, Neuclare, utilizes low-intensity ultrasound to enhance cerebrospinal fluid flow and accelerate the discharge of beta-amyloid from the brain, successfully demonstrating clinical improvements in cognitive functions. Backed by the…
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.